[go: up one dir, main page]

RU2018139523A3 - - Google Patents

Download PDF

Info

Publication number
RU2018139523A3
RU2018139523A3 RU2018139523A RU2018139523A RU2018139523A3 RU 2018139523 A3 RU2018139523 A3 RU 2018139523A3 RU 2018139523 A RU2018139523 A RU 2018139523A RU 2018139523 A RU2018139523 A RU 2018139523A RU 2018139523 A3 RU2018139523 A3 RU 2018139523A3
Authority
RU
Russia
Application number
RU2018139523A
Other versions
RU2747258C2 (ru
RU2018139523A (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2018139523A publication Critical patent/RU2018139523A/ru
Publication of RU2018139523A3 publication Critical patent/RU2018139523A3/ru
Application granted granted Critical
Publication of RU2747258C2 publication Critical patent/RU2747258C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/409Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135Compounds containing heavy metals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0076PDT with expanded (metallo)porphyrins, i.e. having more than 20 ring atoms, e.g. texaphyrins, sapphyrins, hexaphyrins, pentaphyrins, porphocyanines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
RU2018139523A 2016-04-10 2017-04-10 Комбинированные способы терапии для лечения злокачественной опухоли RU2747258C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662320549P 2016-04-10 2016-04-10
US62/320,549 2016-04-10
PCT/IL2017/050440 WO2017179053A1 (en) 2016-04-10 2017-04-10 Combinational therapies for treatment of cancer comprising a bacteriochlorophyll derivative

Related Child Applications (1)

Application Number Title Priority Date Filing Date
RU2021110230A Division RU2021110230A (ru) 2016-04-10 2017-04-10 Комбинированные способы терапии для лечения злокачественной опухоли

Publications (3)

Publication Number Publication Date
RU2018139523A RU2018139523A (ru) 2020-05-15
RU2018139523A3 true RU2018139523A3 (ru) 2020-07-07
RU2747258C2 RU2747258C2 (ru) 2021-04-29

Family

ID=58794130

Family Applications (2)

Application Number Title Priority Date Filing Date
RU2021110230A RU2021110230A (ru) 2016-04-10 2017-04-10 Комбинированные способы терапии для лечения злокачественной опухоли
RU2018139523A RU2747258C2 (ru) 2016-04-10 2017-04-10 Комбинированные способы терапии для лечения злокачественной опухоли

Family Applications Before (1)

Application Number Title Priority Date Filing Date
RU2021110230A RU2021110230A (ru) 2016-04-10 2017-04-10 Комбинированные способы терапии для лечения злокачественной опухоли

Country Status (14)

Country Link
US (2) US11278555B2 (ru)
EP (1) EP3442582A1 (ru)
JP (2) JP2019510807A (ru)
KR (2) KR20190008206A (ru)
CN (2) CN109862918A (ru)
AU (2) AU2017250732B2 (ru)
BR (1) BR112018070847A2 (ru)
CA (1) CA3020067A1 (ru)
IL (1) IL262191B2 (ru)
MX (2) MX390751B (ru)
RU (2) RU2021110230A (ru)
SG (1) SG11201808849TA (ru)
WO (1) WO2017179053A1 (ru)
ZA (1) ZA201807187B (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10107240B2 (en) 2014-04-04 2018-10-23 Dayco Ip Holdings, Llc Check valves and Venturi devices having the same
EP3148852B1 (en) 2014-05-30 2021-03-24 Dayco IP Holdings, LLC Vacuum creation system having an ejector, pneumatic control valve and optionally an aspirator
WO2019116376A1 (en) * 2017-12-17 2019-06-20 Yeda Research And Development Co. Ltd. Cop9 signalosome (csn) complex modulators and uses thereof
WO2022149934A1 (ko) * 2021-01-08 2022-07-14 가톨릭대학교 산학협력단 암세포의 항암 면역치료를 위한 항체-폴리에틸렌글리콜-광감각제 접합체

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1137411T1 (sl) 1998-12-09 2007-10-31 Yeda Res & Dev S paladijem substituirani bakterioklorofilni derivati in njihova uporaba
IL133253A0 (en) 1999-12-01 2001-04-30 Yeda Res & Dev Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them
IL152900A0 (en) * 2002-11-17 2003-06-24 Yeda Res & Dev Water-soluble bacteriochlorophyll derivatives and their pharmaceutical uses
DK2061512T3 (da) 2006-08-23 2020-01-20 Yeda Res & Dev Konjugater af rgd-peptider og (bakterie)chlorophylfotosensibilisatorer samt anvendelser deraf
WO2010046900A2 (en) 2008-10-23 2010-04-29 Steba Biotech N.V. Rgd-containing peptidomimetics and uses thereof
AU2012212323A1 (en) 2011-02-01 2013-09-12 The Board Of Trustees Of The University Of Illinois HDAC inhibitors and therapeutic methods using the same
TWI442945B (zh) * 2011-05-18 2014-07-01 Univ Nat Taiwan 雙效微脂體用於治療的方法
WO2014141289A1 (en) 2013-03-12 2014-09-18 Amrita Vishwa Vidyapeetham University Photo - chemo composition on the basis of microcapsules with a core -shell structure

Also Published As

Publication number Publication date
SG11201808849TA (en) 2018-11-29
AU2017250732A1 (en) 2018-11-15
KR20190008206A (ko) 2019-01-23
MX2018012392A (es) 2019-08-21
IL262191B2 (en) 2025-01-01
AU2017250732B2 (en) 2022-11-10
IL262191A (en) 2018-11-29
US20190125769A1 (en) 2019-05-02
CN118304400A (zh) 2024-07-09
JP2022031823A (ja) 2022-02-22
CA3020067A1 (en) 2017-10-19
KR20220139445A (ko) 2022-10-14
AU2023200591A1 (en) 2023-03-09
MX390751B (es) 2025-03-21
EP3442582A1 (en) 2019-02-20
RU2747258C2 (ru) 2021-04-29
RU2018139523A (ru) 2020-05-15
MX2022003190A (es) 2022-04-11
US11278555B2 (en) 2022-03-22
BR112018070847A2 (pt) 2019-02-05
CN109862918A (zh) 2019-06-07
US20220202838A1 (en) 2022-06-30
WO2017179053A1 (en) 2017-10-19
RU2021110230A (ru) 2021-05-26
IL262191B1 (en) 2024-09-01
JP2019510807A (ja) 2019-04-18
ZA201807187B (en) 2020-01-29

Similar Documents

Publication Publication Date Title
BR112019009389A2 (ru)
BR122021013712A2 (ru)
BR122020022459A2 (ru)
BR112019009192A2 (ru)
RU2018139523A3 (ru)
BR202016025584U2 (ru)
BR202016021516U2 (ru)
CN303537689S (ru)
CN303538000S (ru)
CN303536129S (ru)
CN303536208S (ru)
CN303536232S (ru)
CN303536246S (ru)
CN303536269S (ru)
CN303536362S (ru)
CN303536516S (ru)
CN303536549S (ru)
CN303536736S (ru)
CN303537271S (ru)
CN303537358S (ru)
CN303537427S (ru)
CN303537519S (ru)
CN303537566S (ru)
CN303537608S (ru)
CN303690018S (ru)